Table 3. Late Adverse Events of Patients by Treatment Group.

Adverse event	Events, No. (%)															P valuea
	Paclitaxel plus fluorouracil (n = 107)					Paclitaxel plus cisplatin (n = 107)					Paclitaxel plus carboplatin (n = 107)
	Grade 1	Grade 2	Grade 3	Grade 4	Grade 5	Grade 1	Grade 2	Grade 3	Grade 4	Grade 5	Grade 1	Grade 2	Grade 3	Grade 4	Grade 5
Cardiac	9 (8.4)	5 (4.7)	0	0	0	9 (8.4)	0	0	0	0	15 (14.0)	1 (0.9)	0	0	0	.32
Esophagitis	8 (7.5)	5 (4.7)	3 (2.8)	1 (0.9)	0	5 (4.7)	2 (1.9)	1 (0.9)	0	0	3 (2.8)	2 (1.9)	1 (0.9)	0	0	.03
Pneumonitis	33 (30.8)	5 (4.7)	0	0	0	29 (27.1)	6 (5.6)	0	0	0	32 (29.9)	2 (1.9)	1 (0.9)	0	0	.88

^a P values compared all grade late adverse events among 3 groups.